Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings

• Main Authors: Irsan Hasan (Author), Ignatia Sinta Murti (Author), Putut Bayupurnama (Author), Kemal Fariz Kalista (Author), Christina Hill-Zabala (Author), Dennis Kananda (Author), Elisabet Viayna (Author)
• Format: Book
• Published: BioExcel Publishing Ltd, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Human albumin (HA) is an effective adjuvant treatment for patients with cirrhosis developing spontaneous bacterial peritonitis (SBP), hepatorenal syndrome (HRS) and ascites requiring large-volume paracentesis (LVP). However, cost remains a barrier to use, particularly in resource-limited...